US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist
  • 4.000
  • +0.140+3.63%
Close May 15 16:00 ET
  • 4.190
  • +0.190+4.75%
Post 16:30 ET
219.72MMarket Cap-2150P/E (TTM)

Prelude Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Apr 30, 2024

Based on 3 analysts giving stock ratings to Prelude Therapeutics in the past 3 months

Buy

  • Buy

    33.33%

  • Hold

    66.67%

  • Sell

    0.00%

Price Target

Updated: Apr 30, 2024

The average Prelude Therapeutics stock price target is 5.00 with a max estimate of 7.00 and a min estimate of 3.00

Review Prelude Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Apr 30, 2024

Buy

  • Buy

    33.33%

  • Hold

    66.67%

  • Sell

    0.00%

Price Target

Updated: Apr 30, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg